SecurityCDZI / Cadiz, Inc. (127537207)
IndustryWater Supply
Institutional Owners69
Institutional Shares11,609,179 - 49.57%
Common Shares Outstanding23,419,752 shares (as of 2018-03-31)
Institutional Value$ 321,739,000 USD

Institutional Stock Ownership and Shareholders()

Cadiz, Inc. (NASDAQ:CDZI) has 69 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 11,609,179 shares. Largest shareholders include Water Asset Management LLC, American Assets Capital Advisers, Odey Asset Management Group Ltd, BlackRock Inc., Vanguard Group Inc, Elkhorn Partners Limited Partnership, Credit Suisse Ag/, State Street Corp, Northern Trust Corp, and Susquehanna International Group, Llp.
Cadiz, Inc. (NASDAQ:CDZI) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR BARCLAYS PLC 3,406 4,470 31.24 48 60 25.00
2018-05-15 13F-HR DEUTSCHE BANK AG\ 48,094 23,325 -51.50 684 314 -54.09
2018-05-10 13F-HR JP Morgan Chase & Co 4,618 4,310 -6.67 66 58 -12.12
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 2,940 3,347 13.84 42 46 9.52
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 52,280 52,280 0.00 745 706 -5.23
2017-02-10 13F-HR BlackRock Fund Advisors 44,119 45,609 3.38 327 570 74.31
2018-05-10 13F-HR KINGS POINT CAPITAL MANAGEMENT 75,000 75,000 0.00 1,069 1,013 -5.24
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA Put 45,000 0 -100.00 641,250 0 -100.00
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 3,192 0 -100.00 45 0 -100.00
2018-04-19 13F-HR Janney Montgomery Scott LLC 38,300 36,181 -5.53 546 488 -10.62
2018-05-14 13F-HR TEACHERS ADVISORS INC 39,757 37,167 -6.51 567 502 -11.46
2018-05-14 13F-HR MORGAN STANLEY 43,109 45,028 4.45 614 608 -0.98
2017-02-10 13F-HR BlackRock Advisors LLC 2,708 4,834 78.51 20 60 200.00
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 203,546 205,032 0.73 2,900 2,767 -4.59
2018-05-15 13F-HR UNITED CAPITAL FINANCIAL ADVISERS, LLC 12,823 12,823 0.00 183 173 -5.46
2018-05-09 13F-HR BlackRock Inc. 1,230,015 1,220,146 -0.80 17,528 16,474 -6.01
2018-05-09 13F-HR GABELLI FUNDS LLC 15,000 15,000 0.00 214 203 -5.14
2018-05-17 13F-HR Legal & General Group Plc 3,489 3,489 0.00 50 47 -6.00
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 216,700 236,200 9.00 3,088 3,189 3.27
2018-05-15 13F-HR UBS Group AG 3,303 734 -77.78 47 10 -78.72
2018-05-14 13F-HR ELKHORN PARTNERS LIMITED PARTNERSHIP 451,821 436,128 -3.47 6,839 6,289 -8.04
2018-05-15 13F-HR STATE STREET CORP 325,719 340,328 4.49 4,638 4,593 -0.97
2018-05-15 13F-HR CREDIT SUISSE AG/ 515,236 432,514 -16.06 7,342 5,839 -20.47
2018-04-06 13F-HR Waverton Investment Management Ltd 162,404 162,318 -0.05 2,314 2,191 -5.32
2018-05-09 13F-HR NORTHERN TRUST CORP 263,907 270,318 2.43 3,761 3,650 -2.95
2018-05-15 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 6,449 7,647 18.58 92 103,235 112,111.96
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 18,299 17,880 -2.29 261 241 -7.66
2018-05-11 13F-HR Cutler Group LP Put 1,500 0 -100.00 0 0
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 64,974 218,829 236.79 481 2,735 468.61
2018-05-15 13F-HR Marshall Wace LLP 73,884 60,884 -17.60 1,053 822 -21.94
2018-04-17 13F-HR INGALLS & SNYDER LLC 224,300 221,700 -1.16 3,196 2,993 -6.35
2018-05-15 13F-HR PEAK6 Investments, L.P. Call 3,800 0 -100.00 54 0 -100.00
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 42,056 48,956 16.41 600 661 10.17
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 51,268 53,903 5.14 731 727 -0.55
2018-05-15 13F-HR PEAK6 Investments, L.P. 7,576 0 -100.00 108 0 -100.00
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 12,000 12,000 0.00 171 162 -5.26
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 52,800 0 -100.00 752 0 -100.00
2018-05-15 13F-HR Bank of New York Mellon Corp 81,079 83,453 2.93 1,155 1,126 -2.51
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 3,770 10,206 170.72 54 138 155.56
2018-05-15 13F-HR Water Asset Management LLC 2,967,162 2,967,162 0.00 42,282 40,057 -5.26
2017-07-27 13F-HR Spot Trading L.l.c. Call 10,400 140
2018-05-15 13F-HR WOLVERINE TRADING, LLC Put 18,000 0 -100.00 257 0 -100.00
2018-05-04 13F-HR B. Riley Financial, Inc. 0 10,000 0 135
2018-05-04 13F-HR Boston Partners 150,130 0 -100.00 2,140 0 -100.00
2018-04-26 13F-HR SIMPLEX TRADING, LLC Put 50 10 -80.00 0 0
2018-05-11 13F-HR CITADEL ADVISORS LLC Call 10,300 139
2018-05-15 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 88,200 88,200 0.00 1,257 1,191 -5.25
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 1,834 1,834 0.00 26 25 -3.85
2018-05-11 13F-HR Russell Investments Group, Ltd. 143,885 0 -100.00 2,050 0 -100.00
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 22,300 22,300 0.00 318 301 -5.35
2018-05-10 13F-HR MCF Advisors LLC 500 500 0.00 7 7 0.00
2018-05-09 13F-HR GAMCO INVESTORS, INC. ET AL 10,000 10,000 0.00 143 135 -5.59
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Call 18,400 24,000 30.43 262 324 23.66
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 91,604 104,954 14.57 1,305 1,417 8.58
2017-05-01 13F-HR Spot Trading L.L.C Call 18,700 281
2018-04-20 13F-HR FIRST MANHATTAN CO 31,500 31,500 0.00 448 425 -5.13
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 28,208 28,208 0.00 402 381 -5.22
2018-04-30 13F-HR James Hambro & Partners 17,400 17,400 0.00 249 235 -5.62
2018-05-09 13F-HR Teton Advisors, Inc. 45,174 45,174 0.00 644 610 -5.28
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 33,749 33,098 -1.93 481 447 -7.07
2018-05-11 13F-HR Cutler Group LP 4,571 0 -100.00 65 0 -100.00
2018-05-15 13F-HR Metlife Investment Advisors, Llc 10,537 10,537 0.00 150 142 -5.33
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 14,422 13,686 -5.10 206 185 -10.19
2018-04-26 13F-HR SIMPLEX TRADING, LLC Call 554 511 -7.76 53 18 -66.04
2018-05-15 13F-HR D. E. Shaw & Co., Inc. 11,667 0 -100.00 166 0 -100.00
2018-05-15 13F-HR VANGUARD GROUP INC 966,763 1,024,823 6.01 13,777 13,835 0.42
2017-01-24 13F-HR SPHINX TRADING, LP 7 0 -100.00 0 0
2018-05-04 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 21,073 21,073 0.00 300 284 -5.33
2018-05-09 13F-HR KBC Group NV 209,838 222,674 6.12 2,990 3,006 0.54
2018-05-11 13F-HR CITIGROUP INC 3,169 109 -96.56 46 1 -97.83
2018-05-11 13F-HR Compagnie Odier SCA 7,100 7,100 0.00 101 96 -4.95
2018-05-15 13F-HR TORTOISE INDEX SOLUTIONS, LLC 731 1,144 56.50 10 15 50.00
2018-05-02 13F-HR RHUMBLINE ADVISERS 20,080 20,665 2.91 286 279 -2.45
2017-02-10 13F-HR BlackRock Investment Management, LLC 2,921 2,921 0.00 22 37 68.18
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Call 0 10,300 0 139
2018-05-11 13F-HR Close Asset Management Ltd 1,000 1,000 0.00 14 14 0.00
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 17,571 4,579 -73.94 250,387 61,816 -75.31
2018-05-15 13F-HR Odey Asset Management Group Ltd 1,264,363 1,264,363 0.00 18,017 17,069 -5.26
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 322 0 -100.00 5 0 -100.00
2018-05-04 13F-HR Ironsides Asset Advisors, LLC 12,680 12,280 -3.15 181 166 -8.29
2018-05-15 13F-HR Invesco Ltd. 94,432 96,002 1.66 1,346 1,296 -3.71
2018-05-15 13F-HR AQR CAPITAL MANAGEMENT LLC 15,580 15,504 -0.49 222 209 -5.86
2018-05-15 13F-HR WOLVERINE TRADING, LLC Call 12,300 0 -100.00 175 0 -100.00
2017-07-27 13F-HR Spot Trading L.l.c. Put 5,000 68
2018-05-02 13F-HR American Assets Capital Advisers 1,181,500 1,350,532 14.31 16,836 18,232 8.29
2018-05-15 13F-HR HighTower Advisors, LLC 16,018 14,018 -12.49 228 190 -16.67

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Related News Stories

BRIEF-Cadiz Inc Board Of Directors To Add Representatives From Water Asset Management

2018-05-02 reuters
* CADIZ SAYS BOARD WILL EXPAND FROM 9 TO 11 MEMBERS TO ACCOMMODATE ADDITION OF WATER ASSET MANAGEMENT DESIGNEES (1-0)

Cadiz: A Risky Potential Short

2018-04-23 seekingalpha
Following Warren Buffett’s example, I subscribe to Value Line and scan through the pages looking for an investment opportunity that is a clear buy or short. Guy Spier - Aquamarine Capital - once said that if you have to make a spreadsheet to analyze the nuances of valuation, it’s probably not for a value investor. I have adopted this mentality and only look for blatantly obvious investments, long or short. (16-0)

First Trust Water ETF - Water For Traditional Indexers - Update

2018-04-11 seekingalpha
Over the previous few articles we have been discussing socially responsible and faith based investing. As a subset of socially responsible investing we have water and water infrastructure. (72-1)

California water district rejects Cadiz Inc.'s proposed Mojave Desert water project

2018-03-22 desertsun
Cadiz Inc plans to pump the Mojave Desert aquifer and transport that water to southern California communities. Jay Calderon/The Desert Sun (13-1)

CUSIP: 127537207